These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15047620)
61. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587 [TBL] [Abstract][Full Text] [Related]
62. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130 [TBL] [Abstract][Full Text] [Related]
63. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373 [TBL] [Abstract][Full Text] [Related]
64. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Knobler H; Savion N; Shenkman B; Kotev-Emeth S; Varon D Thromb Res; 1998 May; 90(4):181-90. PubMed ID: 9692617 [TBL] [Abstract][Full Text] [Related]
65. Metabolic effects of dietary fructose in diabetic subjects. Bantle JP; Swanson JE; Thomas W; Laine DC Diabetes Care; 1992 Nov; 15(11):1468-76. PubMed ID: 1468273 [TBL] [Abstract][Full Text] [Related]
66. Effect of alpha-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics. Ble-Castillo JL; Carmona-Díaz E; Méndez JD; Larios-Medina FJ; Medina-Santillán R; Cleva-Villanueva G; Díaz-Zagoya JC Biomed Pharmacother; 2005 Jul; 59(6):290-5. PubMed ID: 15932790 [TBL] [Abstract][Full Text] [Related]
67. [Lipid profile in diabetic patients, according to changes in glucose control: a 2-year study]. Sancho Serrano MA; Jiménez Aznarez A; Sanz París A An Med Interna; 1993 Oct; 10(10):479-83. PubMed ID: 8136424 [TBL] [Abstract][Full Text] [Related]
68. Action of platelet-activating factor on type 1 diabetic human platelets. Greco NJ; Arnold JH; O'Dorisio TM; Cataland S; Panganamala RV J Lab Clin Med; 1985 Apr; 105(4):410-6. PubMed ID: 3981054 [TBL] [Abstract][Full Text] [Related]
69. Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control. Sözmen B; Delen Y; Girgin FK; Sözmen EY Clin Biochem; 1999 Aug; 32(6):423-7. PubMed ID: 10667477 [TBL] [Abstract][Full Text] [Related]
70. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus. Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874 [TBL] [Abstract][Full Text] [Related]
71. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449 [TBL] [Abstract][Full Text] [Related]
72. The role of adenosine triphosphate citrate lyase in the metabolism of acetyl coenzyme a and function of blood platelets in diabetes mellitus. Michno A; Skibowska A; Raszeja-Specht A; Cwikowska J; Szutowicz A Metabolism; 2004 Jan; 53(1):66-72. PubMed ID: 14681844 [TBL] [Abstract][Full Text] [Related]
73. Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets. Pratico D; Lawson JA; Fitzgerald GA Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():229-31. PubMed ID: 7732840 [No Abstract] [Full Text] [Related]
74. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets. Schafer AI; Turner NA; Handin RI Biochim Biophys Acta; 1982 Sep; 712(3):535-41. PubMed ID: 6812645 [TBL] [Abstract][Full Text] [Related]
75. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Drexel H; Aczel S; Marte T; Benzer W; Langer P; Moll W; Saely CH Diabetes Care; 2005 Jan; 28(1):101-7. PubMed ID: 15616241 [TBL] [Abstract][Full Text] [Related]
76. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification. Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196 [TBL] [Abstract][Full Text] [Related]
77. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982 [TBL] [Abstract][Full Text] [Related]
78. Platelet function in male diabetics with and without macrovascular complications. Tóth L; Szénási P; Jámbor G; Kammerer L; Romics L Diabetes Res Clin Pract; 1992 Feb; 15(2):143-8. PubMed ID: 1563330 [TBL] [Abstract][Full Text] [Related]
79. Arachidonic acid metabolism in the neonatal platelet. Stuart MJ; Allen JB Pediatrics; 1982 Jun; 69(6):714-8. PubMed ID: 6804924 [TBL] [Abstract][Full Text] [Related]
80. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]